MX2016002529A - Marcadores de riesgo para cardiovasculopatias en pacientes con nefropatia cronica. - Google Patents

Marcadores de riesgo para cardiovasculopatias en pacientes con nefropatia cronica.

Info

Publication number
MX2016002529A
MX2016002529A MX2016002529A MX2016002529A MX2016002529A MX 2016002529 A MX2016002529 A MX 2016002529A MX 2016002529 A MX2016002529 A MX 2016002529A MX 2016002529 A MX2016002529 A MX 2016002529A MX 2016002529 A MX2016002529 A MX 2016002529A
Authority
MX
Mexico
Prior art keywords
disease
chronic kidney
patients
cardiovascular disease
risk
Prior art date
Application number
MX2016002529A
Other languages
English (en)
Inventor
Eduardo Salas
Roberto Elosua
Sergio Castillo
Sara Pich
Manuel Arias
Original Assignee
Gendiag Exe Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49054458&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2016002529(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gendiag Exe Sl filed Critical Gendiag Exe Sl
Publication of MX2016002529A publication Critical patent/MX2016002529A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La invención se refiere a un método para determinar el riesgo que presenta un sujeto que padece una nefropatía crónica de sufrir una cardiovasculopatía, sobre la base de la presencia de diferentes polimorfismos, así como también se refiere a kits para practicar los métodos anteriores. La invención también se refiere a un método para determinar el riesgo de padecer una cardiovasculopatía al combinar la ausencia o la presencia de uno o más marcadores polimórficos en una muestra obtenida de un sujeto con factores de riesgo clínicos/bioquímicos para la CVD, además de los medios de implementación informática para llevar a cabo dicho método.
MX2016002529A 2013-08-30 2014-08-29 Marcadores de riesgo para cardiovasculopatias en pacientes con nefropatia cronica. MX2016002529A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13182484.9A EP2843056B8 (en) 2013-08-30 2013-08-30 Risk markers for cardiovascular disease in patients with chronic kidney disease
PCT/EP2014/068387 WO2015028612A1 (en) 2013-08-30 2014-08-29 Risk markers for cardiovascular disease in patients with chronic kidney disease

Publications (1)

Publication Number Publication Date
MX2016002529A true MX2016002529A (es) 2016-06-21

Family

ID=49054458

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016002529A MX2016002529A (es) 2013-08-30 2014-08-29 Marcadores de riesgo para cardiovasculopatias en pacientes con nefropatia cronica.

Country Status (13)

Country Link
US (1) US20160215341A1 (es)
EP (2) EP2843056B8 (es)
JP (1) JP2016528907A (es)
AR (1) AR097489A1 (es)
AU (1) AU2014314097A1 (es)
CA (1) CA2922329A1 (es)
CL (1) CL2016000447A1 (es)
MX (1) MX2016002529A (es)
PE (1) PE20160603A1 (es)
RU (1) RU2656148C2 (es)
SG (1) SG11201601490XA (es)
UY (1) UY35719A (es)
WO (1) WO2015028612A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108172296A (zh) * 2018-01-23 2018-06-15 上海其明信息技术有限公司 一种数据库的建立方法和遗传疾病的风险预测方法
CN108897985A (zh) * 2018-05-04 2018-11-27 上海市内分泌代谢病研究所 一种糖化血红蛋白HbA1c遗传位点评分的方法及其应用
CN111354464B (zh) * 2018-12-24 2024-05-17 深圳先进技术研究院 Cad预测模型建立方法、装置以及电子设备
RU2709837C1 (ru) * 2019-03-29 2019-12-23 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) (ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Се Способ прогнозирования вероятности интраоперационных и ранних послеоперационных осложнений при органосохраняющих операциях при опухолях паренхимы почек
CN112034189B (zh) * 2020-06-16 2023-03-17 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） 内皮素-1作为用于评价原发性慢性肾脏病患者无症状心血管器官损伤的标志物的应用
CN113643753B (zh) * 2021-05-26 2022-07-26 中国医学科学院阜外医院 冠心病多基因遗传风险评分及联合临床风险评估应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883750A (en) 1984-12-13 1989-11-28 Applied Biosystems, Inc. Detection of specific sequences in nucleic acids
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US6159693A (en) 1998-03-13 2000-12-12 Promega Corporation Nucleic acid detection
WO2008060618A2 (en) * 2006-11-15 2008-05-22 University Of Florida Research Foundation Use of genetic determinants in cardiovascular risk assessment
WO2009117122A2 (en) * 2008-03-19 2009-09-24 Existence Genetics Llc Genetic analysis
EP2264183B1 (en) * 2009-06-09 2016-12-07 Gendiag.exe, S.L. Risk markers for cardiovascular disease
ES2387292B1 (es) * 2010-06-29 2013-10-30 Fundacio Institut De Recerca Hospital Universitari Vall D'hebron Combinacion de snps para determinar el riesgo de sufrir una enfermedad neurovascular
PL2554679T3 (pl) * 2011-08-05 2016-09-30 Markery genetyczne do oceny ryzyka choroby układu sercowo-naczyniowego
WO2013080227A1 (en) * 2011-11-28 2013-06-06 Decode Genetics Ehf Genetic variants useful for risk assessment of arterial disease

Also Published As

Publication number Publication date
EP2843056B1 (en) 2019-04-10
EP2843056B8 (en) 2019-06-26
US20160215341A1 (en) 2016-07-28
RU2656148C2 (ru) 2018-05-31
RU2016111308A (ru) 2017-10-05
JP2016528907A (ja) 2016-09-23
WO2015028612A1 (en) 2015-03-05
CL2016000447A1 (es) 2016-12-09
EP3039156A1 (en) 2016-07-06
PE20160603A1 (es) 2016-07-03
AR097489A1 (es) 2016-03-16
AU2014314097A1 (en) 2016-03-24
EP3039156B1 (en) 2019-01-02
UY35719A (es) 2015-01-30
EP2843056A1 (en) 2015-03-04
CA2922329A1 (en) 2015-03-05
SG11201601490XA (en) 2016-03-30

Similar Documents

Publication Publication Date Title
MX2011013243A (es) Marcadores de riesgo para enfermedad cardiovascular.
MX340453B (es) Biomarcadores para cancer de pulmon.
EA201590027A1 (ru) Способы детекции заболеваний или состояний
MX2016002529A (es) Marcadores de riesgo para cardiovasculopatias en pacientes con nefropatia cronica.
TN2013000464A1 (en) Biomarkers for hedgehog inhibitor therapy
MX360663B (es) Enfermedad tromboembolica.
WO2013033609A3 (en) Methods and compositions for the treatment and diagnosis of cancer
WO2015061634A3 (en) Biomarkers and diagnostic methods for alzheimer's disease and other neurodegenerative disorders
WO2012159025A3 (en) Chromosome conformation analysis
EA201390149A1 (ru) Способы выявления заболевания или патологических состояний с использованием фагоцитарных клеток
MX356640B (es) Enfermedad cardiovascular.
WO2016057702A3 (en) Methods for prognosing and preventing metastatic liver disease
MX357429B (es) Predictores para el tratamiento del cáncer.
MX2016001719A (es) Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular.
MX2014006187A (es) Composiciones y metodos para el analisis de cancer de prostata.
WO2012145516A3 (en) Methods and kits for quantitative determination of total organic acid content in a coolant
AU2012371260A8 (en) Predicitive biomarker for cancer treatment with ADCC enhanced antibodies
GB201101400D0 (en) Detection method
GB201114909D0 (en) Biomarkers for lysosomal storage disorders
MX2015009726A (es) Metodo para la prediccion de la aparicion de sintomas extrapiramidales (sep) inducidos por un tratamiento con antipsicoticos.
IN2014DN08312A (es)
WO2013040358A3 (en) Assays and compositions for detection of agr2
WO2015091902A3 (en) Determination of platelet-mirnas in alzheimer's disease
WO2015013455A3 (en) Methods and compositions for the treatment and diagnosis of cancer
WO2013072393A3 (de) Neues verfahren zur identifizierung von spezifischen markersequenzen für prostatakrebs